MucosaTec is a German biotech start-up developing next-generation, locally acting therapeutics for infectious diseases. Our vision is to strengthen the natural barrier function of mucus and enable rapid, immune-independent protection at mucosal surfaces, with a special focus on influenza. Our versatile platform technology enables us to actively broaden our pipeline to additional pathogens, addressing unmet medical needs across infectious diseases.
| Website | https://mucosatec.eu/ |
| Employees | 8 (5 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Membrane, Bioengineering, Tissue Engineering, Biomaterials, Biological Engineering, Regenerative Medicine, Therapeutics, Drug Delivery, Cell Culture, Medical Devices, Surface Science, Molecular Biology, Biosensors, Pharmaceutical, Immunology, Biophysics |
| Competitors | Boehringer Ingelheim, Genentech, Amgen, AstraZeneca, Pfizer, Novartis, Johnson & Johnson, Roche, Bristol Myers Squibb, Gilead Sciences +44 more (view full list) |
Looking for a particular MucosaTec employee's phone or email?
MucosaTec Questions
Marius Hittinger is the CEO of MucosaTec.
5 people are employed at MucosaTec.
MucosaTec is based in Schiffweiler, Saarland.
Top MucosaTec Employees
-
2
-
2
-
Juan Undefined
Gerente general at MucosaTec
San Carlos de Bariloche, Río Negro Province, AR
